You are on page 1of 6

Encore Company Mittar, Sarv

Device: BiPAP AVAPS 30 (System One 60 Series) (1161T) (C174914064859 3.05.01)

Trend Report

Patient: Patient ID: EncoreCompany6


Mittar, Sarv
Home Phone:
Date of Birth:
Age:
Mask:
Sleep Doctor:
Group/Practice:
Phone:
Fax:
E-Mail Address:
PCP:
Phone:
Clinician:
Administrator, New
Compliance Information 12/30/2021 - 1/28/2022

Device Settings as of 1/28/2022


Device Mode S/T - AVAPS
Device Settings
Parameter Value
Max IPAP 30 cmH2O
Min IPAP 14 cmH2O
EPAP Pressure 8 cmH2O
Breath Rate 16
Timed Inspiration 1
Tidal Volume 450
Rise Time Setting 3
Rise Time Lock On
Ramp Off
Mask Resistance Off
Mask Resistance Lock Off
Tubing Type 22
Tubing Type Lock Off
Disconnect Alarm Off
Apnea Alarm Off
Low Minute Ventilation Alarm Off
Low Tidal Volume Alarm Off
Change Humidifier Settings Yes
Humidification Mode System One
Humidifier Setting 3

Printed By: 2/2/2022 EncorePro - version: 2.21.4.1 Page 1 of 6

This report is only one of several elements to consider when evaluating therapy effectiveness and is not a substitute for diagnostic data.
Patient ID: EncoreCompany6 Mittar, Sarv
Ventilator Statistics by week

12/26/2021

1/16/2022

1/23/2022
1/2/2022

1/9/2022
Min 1.8 0 4.2 0.9 1.3
AHI Max 4 10.4 10.2 8.2 4
Avg 2.8 5.3 6.8 3.3 2.6

Min 7.8 7.8 7.8 7.8 7.9


Attained EPAP Pressure Max 7.9 7.9 7.9 7.9 7.9
Avg 7.9 7.8 7.9 7.9 7.9

Min 16.4 16.3 17 15.8 17.2


Attained IPAP/CPAP
Pressure Max 16.9 17.5 19 18.9 20.4
Avg 16.7 16.8 18 17.3 18.1

Min 17.4 16.7 16.5 16.6 16.3


Breath Rate Max 17.6 18.5 18.2 18.9 17
Avg 17.5 17.5 17.5 17.6 16.7

Min 491 470.7 469.8 471.3 476.2


Exhaled Tidal Volume Max 514 543.5 554 493 504.8
Avg 503.5 498.7 483.5 486 488.1

Min 48.5 47 42 45.4 44.7


Leak Max 77.1 86.8 74.1 50.1 60.5
Avg 62.1 63.7 55.8 47.4 51.4

Min 39.3 23.1 17.8 12.2 10


Percent Patient
Triggered Breaths Max 44 48.9 51 65.5 29.6
Avg 40.9 37.4 38.4 38.6 20.7

Min 42 40.6 43.8 41.4 39.7


Peak Inspiratory Flow Max 44.5 51.3 48.8 47.1 44.9
Avg 43.5 45.2 45.5 43.9 42.5

Min 8.1 7.4 7.9 7.6 7.6


Minute Vent Max 8.6 9.4 8.8 8.6 7.9
Avg 8.4 8.3 8.2 8.2 7.8

Compliance Summary
Date Range 12/30/2021 - 1/28/2022 (30 days)
Percent Days with Device Usage 96.7%
Average Usage (All Days) 2 hrs. 31 mins. 46 secs.
Average Usage (Days Used) 2 hrs. 37 mins.
Percent of Days with Usage >= 4 Hours 16.7%

Printed By: 2/2/2022 EncorePro - version: 2.21.4.1 Page 2 of 6

This report is only one of several elements to consider when evaluating therapy effectiveness and is not a substitute for diagnostic data.
Patient ID: EncoreCompany6 Mittar, Sarv
Pressure (cmH2O)

Average IPAP
17.4

Average EPAP
7.9

Printed By: 2/2/2022 EncorePro - version: 2.21.4.1 Page 3 of 6

This report is only one of several elements to consider when evaluating therapy effectiveness and is not a substitute for diagnostic data.
Patient ID: EncoreCompany6 Mittar, Sarv
Tidal Volume (ml)

Average Tidal Volume


491.9 ml

High Tidal Volume


554.0 ml

Low Tidal Volume


469.8 ml

Minute Vent

Average Minute Vent


8.2

High Minute Vent


9.4

Low Minute Vent


7.4

Breaths Per Minute

Average Breath Rate


17.4 bpm

High Breath Rate


18.9 bpm

Low Breath Rate


16.3 bpm

Patient Triggered Breaths (%)


Average % Patient
Triggered Breaths
35.4%
High % Patient Triggered
Breaths
65.5%
Low % Patient Triggered
Breaths
10.0%

Printed By: 2/2/2022 EncorePro - version: 2.21.4.1 Page 4 of 6

This report is only one of several elements to consider when evaluating therapy effectiveness and is not a substitute for diagnostic data.
Patient ID: EncoreCompany6 Mittar, Sarv
AHI

Average AHI
4.3

Printed By: 2/2/2022 EncorePro - version: 2.21.4.1 Page 5 of 6

This report is only one of several elements to consider when evaluating therapy effectiveness and is not a substitute for diagnostic data.
Patient ID: EncoreCompany6 Mittar, Sarv
Leak (LPM)

Average Total Leak


56.3

Device Humidification Settings

Hours of Usage

Printed By: 2/2/2022 EncorePro - version: 2.21.4.1 Page 6 of 6

This report is only one of several elements to consider when evaluating therapy effectiveness and is not a substitute for diagnostic data.

You might also like